reboxetine has been researched along with Developmental Psychomotor Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elefteriou, F; Hahn, MK; Krueger, JJ; Ma, Y; Nyman, JS; Redmon, SN; Uppuganti, S | 1 |
| Dantchev, N; Widlöcher, DJ | 1 |
2 other study(ies) available for reboxetine and Developmental Psychomotor Disorders
| Article | Year |
|---|---|
Extracellular norepinephrine clearance by the norepinephrine transporter is required for skeletal homeostasis.
Topics: Animals; Antidepressive Agents; Biological Transport, Active; Bone Remodeling; Bone Resorption; Humans; Mice; Mice, Mutant Strains; Morpholines; Neurons; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Osteoclasts; Psychomotor Disorders; Reboxetine; Sympathetic Nervous System | 2013 |
The measurement of retardation in depression.
Topics: Adrenergic Uptake Inhibitors; Adult; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Morpholines; Motor Activity; Psychiatric Status Rating Scales; Psychometrics; Psychomotor Agitation; Psychomotor Disorders; Psychomotor Performance; Reboxetine; Speech | 1998 |